Nothing Special   »   [go: up one dir, main page]

Ward et al., 2007 - Google Patents

Clinical uses of botulinum toxins

Ward et al., 2007

Document ID
2388363981023351927
Author
Ward A
Barnes M
Publication year

External Links

Snippet

Botulinum toxins now play a very significant role in the management of a wide variety of medical conditions; from headaches to hypersalivation, and from spasticity to sweating. In this book, a strong, international team of experts outline the basic neurochemistry of …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Jankovic Botulinum toxin: State of the art
Masuyer et al. Engineered botulinum neurotoxins as new therapeutics
Kumar et al. The botulinum toxin as a therapeutic agent: molecular structure and mechanism of action in motor and sensory systems
Comella et al. Botulinum toxins in neurological disease
KR102617830B1 (en) Cationic neurotoxins
Cherington Botulism: update and review
JP5833039B2 (en) Transport proteins used to introduce compounds into nerve cells
CN102131823A (en) Clostridial neurotoxins with altered persistency
JP2023517724A (en) A modified botulinum neurotoxin for the treatment of limb spasticity
Palazón-García et al. Botulinum toxin: from poison to possible treatment for spasticity in spinal cord injury
Luvisetto et al. Toxicity of botulinum neurotoxins in central nervous system of mice
Raj Botulinum toxin therapy in pain management
EP2085093B1 (en) Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen
Pickett et al. New trends in the science of botulinum toxin-A as applied in dystonia
Ward et al. Clinical uses of botulinum toxins
Kutschenko et al. BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay
Joshi et al. Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments
Lam The basic science of botulinum toxin
JP2007516257A (en) Lipid rafts and clostridial toxins
Malgorzata et al. The mechanism of the beneficial effect of botulinum toxin type a used in the treatment of temporomandibular joints dysfunction
CA2948915C (en) Botulinum toxin for use in the treatment of paratonia
Fonfria Botulinum neurotoxin: a multifunctional protein for the development of new therapeutics
Gracies et al. Botulinum toxin therapy
JP2011157331A (en) Botulinus toxin formulation capable of high-dose administration
Kukreja et al. Basic chemistry of botulinum neurotoxins relevant to vaccines, diagnostics, and countermeasures